{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-016002","form_type":"8-K","ticker":"IBO","cik":"0001834105","company_name":"IMPACT BIOMEDICAL INC.","filed_at":"2025-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.026040+00:00","generated_at":"2026-05-19T00:04:42.904312+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Impact BioMedical announces reverse merger with Dr Ashleys; shareholders to receive 4.80% of combined entity","bullets":["Impact BioMedical (IBO) will merge with Dr Ashleys via a reverse merger; existing Impact shareholders receive 4.80% of the new PubCo's ordinary shares.","Dr Ashleys shareholders get 94.20% of PubCo; Dr Ashleys management will control the combined company's board and operations.","86.81% of Impact's shareholders (by as-converted shares) have signed a voting agreement to approve the deal.","Closing conditions include Impact having at least $10,000 net cash and zero net debt, and NYSE American listing approval.","The combined entity will be renamed Dr Ashleys Limited and continue trading on NYSE American under a new name."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-016002","json":"https://secwatch.observer/filing/0001641172-25-016002.json","markdown":"https://secwatch.observer/filing/0001641172-25-016002.md","text":"https://secwatch.observer/filing/0001641172-25-016002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1834105/000164117225016002/0001641172-25-016002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1834105/000164117225016002/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T00:04:42.904312+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}